Legend Biotech (LEGN) Cash from Discontinued Operations (2019 - 2025)
Legend Biotech's (LEGN) quarterly Cash from Discontinued Operations came in at 106286000.0 in Q1 2025, down 4558.31% YoY from 2384000.0 in Q1 2024, and down 29.49% on a QoQ basis from 82078000.0 in Q4 2024.
Legend Biotech (LEGN) Cash from Discontinued Operations (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 5 years of Cash from Discontinued Operations data on file, last reported at 106286000.0 in Q1 2025.
- Quarterly Cash from Discontinued Operations fell 4558.31% year-over-year to 106286000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 281625000.0 (down 104.54% YoY) and the FY2024 annual result came in at 144033000.0, up 63.38% from the prior year.
- Cash from Discontinued Operations slipped to 106286000.0 in Q1 2025, from 82078000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 2384000.0 in Q1 2024 to a low of 106286000.0 in Q1 2025.
- A 3-year average of 70406250.0 and a median of 88861500.0 in 2023 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2024 — Cash from Discontinued Operations climbed 14.18% — and 2025, when it plunged 4558.31%.
- Tracing LEGN's Cash from Discontinued Operations over 3 years: stood at 95645000.0 in 2023, then advanced by 14.18% to 82078000.0 in 2024, then retreated by 29.49% to 106286000.0 in 2025.
- The last three Cash from Discontinued Operations figures came in at 106286000.0 (Q1 2025), 82078000.0 (Q4 2024), and 2384000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.90 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -106.29 Mn |
| Mar 31, 2025 | -106.29 Mn |
| Dec 31, 2024 | -82.08 Mn |
| Dec 31, 2024 | -82.08 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Sep 30, 2020 | -64.38 Mn |
| Sep 30, 2020 | -64.38 Mn |
| Sep 30, 2019 | 19.95 Mn |
| Sep 30, 2019 | 19.95 Mn |